YK-11: What the Research Says About Benefits, Risks and Evidence

YK-11 is a synthetic compound commonly discussed online as a selective androgen receptor modulator (SARM) and performance-enhancing research compound. It has attracted attention because of claims surrounding muscle growth, strength, follistatin, myostatin and body composition.

However, the scientific evidence surrounding YK-11 is very limited compared with the amount of discussion about it online.

The most frequently cited scientific research on YK-11 is preclinical rather than human clinical research. This distinction is important: findings from laboratory cells do not establish that the same effects will occur in people.

This guide explains what YK-11 is, what researchers have actually studied, what potential benefits are claimed, what is known about its risks, and what remains uncertain.

 

What Is YK-11?

YK-11 is a synthetic compound commonly classified and marketed online as a selective androgen receptor modulator (SARM).

SARMs are compounds designed to interact with androgen receptors. Androgen receptors are involved in biological processes including the development and maintenance of muscle and bone tissue.

For a broader discussion of SARMs and Lean muscle, see our guide to SARMs for Lean Muscle

YK-11 is particularly interesting because early laboratory research investigated effects involving muscle cell differentiation and follistatin expression.

However, YK-11 should not be confused with an established medicine or clinically validated muscle building treatment.

Unlike an approved medication, there is not a large body of controlled human clinical research establishing its effectiveness, appropriate medical use, long-term safety, or therapeutic dosage.

What Does YK-11 Do?

The answer depends on whether we are discussing laboratory findings or claims made about human use.

Laboratory research has investigated YK-11’s effects on muscle related cellular pathways. One frequently cited study examined YK-11 in C2C12 mouse muscle cells and reported effects involving follistatin expression and muscle cell differentiation.

These findings are scientifically interesting, but they do not prove that YK-11 produces a specific amount of muscle growth, strength improvement, fat loss, or athletic performance enhancement in humans.

This distinction is essential when evaluating claims about YK-11:

Laboratory finding → biological hypothesis → human clinical evidence

A laboratory finding can provide a reason for further research, but it should not automatically be presented as a proven benefit in people.

What Research Has Actually Been Done on YK-11?

The research base for YK-11 is small.

The study most commonly associated with YK-11 investigated its effects in cultured C2C12 mouse muscle cells. Researchers observed increased follistatin expression and effects related to myogenic differentiation.

This provides a possible biological explanation for why YK-11 became associated with muscle growth claims.

However, cell studies have important limitations.

A result observed in isolated cells does not tell us:

• Whether the same effect occurs in humans
• How much of the compound would be required to produce an effect
• Whether the effect would translate into meaningful muscle growth
•  What long-term health consequences might occur
• Whether potential benefits outweigh potential risks

Therefore, the available evidence should be described as preclinical and limited, rather than as proof that YK-11 is an effective muscle building compound in humans.

YK-11, Follistatin and Myostatin

One reason YK-11 receives so much attention is its reported relationship with follistatin.

Follistatin is a protein involved in the regulation of several biological processes, including pathways associated with muscle growth. It can interact with myostatin, a protein that acts as an important regulator of muscle development.

The original laboratory research on YK-11 reported increased follistatin expression in cultured muscle cells.

This has led to a simplified claim online:

YK-11 → increased follistatin → reduced myostatin activity → more muscle

The biology is more complicated than that.

The laboratory finding does not establish that taking YK-11 produces predictable muscle growth in humans. It also does not establish that manipulating this pathway with YK-11 is safe over the long term.

Therefore, the follistatin finding should be viewed as a research observation and possible mechanism for further investigation, not as proof of a guaranteed muscle-building effect.

What Are the Claimed Benefits of YK-11?

YK-11 is commonly associated online with several claimed benefits.

Muscle Growth

Muscle growth is the primary reason YK-11 receives attention in bodybuilding communities.

The biological findings involving muscle cells and follistatin provide a possible reason for this interest. However, there is insufficient high-quality human evidence to establish how effective YK-11 is for increasing muscle mass.

Strength and Performance

Some online reports associate YK-11 with increased strength and athletic performance.

These reports are not equivalent to controlled clinical trials.

Without adequate human studies, it is difficult to determine how much of these reported effects are caused by YK-11 itself, training, nutrition, individual differences, other substances, or expectations.

Fat Loss and Body Composition

YK-11 is also sometimes promoted for improving body composition or preserving lean mass during fat loss.

Again, strong human clinical evidence is lacking.

Claims about fat loss should therefore be treated cautiously rather than presented as established effects.

Bone Health

Because androgen-receptor signaling is involved in bone biology, YK-11 has sometimes been discussed in connection with bone health.

However, that does not mean YK-11 has been established as a treatment for osteoporosis or other bone disorders.

There is not sufficient clinical evidence to describe YK-11 as an approved treatment for these conditions.

YK-11 Benefits: What Is Proven and What Is Not?

A useful way to evaluate YK-11 claims is to separate evidence from speculation.

Claim| Current evidence
YK-11 affects muscle-related cellular pathways| Supported by preclinical research
YK-11 affects follistatin expression in laboratory cells| Reported in preclinical research
YK-11 reliably builds muscle in humans| Not established
YK-11 reliably increases strength in humans| Not established
YK-11 causes predictable fat loss| Not established
YK-11 is safe for long-term human use| Not established
YK-11 is an approved medical treatment| No

This distinction is one of the most important points when researching YK-11.

YK-11 Side Effects and Safety Concerns

The biggest problem with evaluating YK-11 safety is the lack of adequate long term human research.

The absence of extensive evidence does not mean a compound is safe. It means there is uncertainty.

Potential concerns surrounding SARMs and related performance-enhancing compounds include hormonal effects, liver injury, cardiovascular effects and other adverse reactions.

 

For YK-11 specifically, the limited research means that its long term safety profile cannot be confidently established.

Hormonal Effects

Compounds that interact with androgen related pathways may affect the body’s hormonal systems.

The extent and duration of these effects with YK-11 are not adequately established through high quality human clinical research.

Liver and Cardiovascular Concerns

The FDA has warned about serious adverse effects associated with SARMs and certain bodybuilding products, including liver injury and cardiovascular risks.

This is one reason why claims that a research compound is simply a “safer alternative” to anabolic steroids should not be accepted without strong evidence.

Long Term Effects

One of the largest unanswered questions is long term safety.

Without adequate long term human studies, researchers cannot confidently determine the consequences of prolonged exposure or establish a reliable risk profile.

YK-11 vs Other Research Compounds

YK-11 is often compared online with compounds such as RAD-140 and LGD-4033.

These comparisons should be made carefully.

Some other SARMs have been investigated in human clinical research, while the evidence surrounding YK-11 remains much more limited.

For example, LGD-4033 and enobosarm have been studied in controlled human research settings. That does not make them approved bodybuilding treatments or establish that they are safe for recreational use, but it does mean their evidence base is different from that of YK-11.

Therefore, it is misleading to claim that YK-11 is definitively stronger, safer, or more effective than another compound when appropriate comparative human trials are lacking.

The better question is:

What evidence exists for each compound, in which population, for which outcome, and with what risks?

Is YK-11 FDA Approved?

No.

YK-11 is not an FDA approved treatment for muscle growth, bodybuilding, fat loss, athletic performance, or osteoporosis.

The FDA has warned consumers about SARMs marketed as bodybuilding products and has emphasized that these products can carry serious health risks.

Therefore, online availability should not be confused with medical approval or proof of safety.

Is YK-11 Prohibited in Sports?

YK-11 is included among prohibited selective androgen receptor modulators under the World Anti Doping Agency’s prohibited list.

Athletes subject to anti doping rules should therefore check the current rules applicable to their sport and governing organization.

What About YK-11 Cancer Claims?

There is not enough human clinical evidence to make a reliable claim that YK-11 causes or prevents cancer.

That does not mean cancer related questions should simply be dismissed. It means the available evidence is insufficient to establish a clear relationship.

Claims about cancer risk should be evaluated using high quality human research rather than bodybuilding forums, testimonials, or marketing material.

Anyone with a medical concern about cancer or a substance’s potential effect on cancer should discuss it with an appropriately qualified healthcare professional.

Why Online YK-11 Claims Can Be Misleading

A large amount of information about YK-11 comes from bodybuilding communities, product sellers, forums and social media.

These sources can be useful for identifying questions that people are asking, but they are not substitutes for controlled scientific research.

Availability does not establish regulatory approval, quality, purity or safety.

“It is a SARM, therefore it is safer than steroids.”

Classification alone does not establish a favorable safety profile.

What We Still Don’t Know About YK-11

Several important questions remain unanswered.

Researchers need better human evidence to determine:

• Whether YK-11 produces meaningful muscle growth in humans
• Whether laboratory findings involving follistatin translate into useful clinical outcomes
• What short term adverse effects may occur
  What long-term effects may occur
•  How YK-11 affects hormonal function
• How it affects cardiovascular health
• How it affects the liver
• Whether potential benefits outweigh potential risks
• How product purity and labeling affect real world exposure

These unanswered questions are important because strong claims require strong evidence.

Can You Build Muscle Without YK-11?

Yes.

Resistance training, adequate nutrition, sufficient protein, recovery, sleep and progressive overload are established components of building and maintaining muscle.

The effectiveness of these fundamentals does not depend on YK-11.

For people interested in improving body composition or athletic performance, a qualified fitness or healthcare professional can help develop an appropriate plan based on individual circumstances.

Frequently Asked Questions

What is YK-11?

YK-11 is a synthetic compound commonly classified online as a SARM. It has attracted attention because of preclinical research involving androgen-receptor activity, follistatin and muscle cell biology. However, human clinical evidence remains very limited.

What does YK-11 do?

Preclinical research has reported effects involving muscle cell differentiation and follistatin expression. However, these findings do not establish predictable muscle growth or performance benefits in humans.

Does YK-11 actually build muscle?

There is not enough high quality human clinical evidence to establish that YK-11 reliably builds muscle in people.

What are the benefits of YK-11?

YK-11 is commonly promoted for muscle growth, strength and body composition improvements. However, most of these claims are not supported by robust human clinical evidence.

What are the side effects of YK-11?

The long term safety profile of YK-11 is not well established. Concerns surrounding SARMs and related compounds include hormonal effects, liver injury and cardiovascular risks.

Are there human studies on YK-11?

The frequently cited YK-11 research is primarily preclinical, including laboratory work involving mouse muscle cells. This is substantially different from controlled human clinical research.

Is YK-11 FDA approved?

No. YK-11 is not an FDA approved treatment for muscle growth, athletic performance or bodybuilding.

Is YK-11 prohibited in sports?

YK-11 is included among prohibited SARMs under the World Anti-Doping Agency’s prohibited list.

Is YK-11 safer than anabolic steroids?

There is not enough evidence to make that conclusion. Lack of evidence about long-term effects should not be interpreted as evidence of safety.

Bottom Line

YK-11 is a compound that has attracted significant attention because of its proposed effects on androgen-related pathways and laboratory findings involving follistatin and muscle cells.

However, the evidence needs to be put into perspective.

The available research does not provide strong human clinical evidence establishing YK-11 as an effective or safe muscle-building treatment. Much of the scientific interest comes from preclinical research, while many of the stronger claims found online come from anecdotal reports and performance-enhancement communities.

The most responsible way to understand YK-11 is therefore to separate what has been observed in laboratory research from what has actually been demonstrated in humans.

Until stronger human research becomes available, claims about its effectiveness, long-term safety, muscle-building ability, fat-loss effects or superiority over other compounds should be treated cautiously.

 

This article is intended for educational purposes only and should not be considered medical advice. Scientific evidence and regulatory information can change as new research becomes available.

References

1. YK-11 and follistatin research: “A novel androgen receptor modulator, YK11, induces myogenic differentiation and promotes skeletal muscle growth.” PubMed PMID: 23995658.

2. FDA safety information: U.S. Food and Drug Administration, warnings concerning SARMs and bodybuilding products.

3. World Anti-Doping Agency: Prohibited List, including selective androgen receptor modulators.

4. Research on myostatin and muscle biology: Scientific literature examining the role of myostatin and follistatin in skeletal muscle regulation.